FHIR IG analytics
Rows 0 - 200 Next
| Package | Identity | Name/Title | Status | FMM | WG | Date | Realm | Resource | Usage # |
|---|---|---|---|---|---|---|---|---|---|
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Account.json | Cross-version Profile for R4B.Account for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Account | 2 |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-activityDefinition-catalogService.json | ActivityDefinition: Usługa katalogowa | active | 2026-01 | pl | ActivityDefinition | 1 | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-ActivityDefinition-test-drug-pq.json | ActivityDefinition - Test Drug PQ | active | brr | 2026-07 | uv | ActivityDefinition | 2 | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ActivityDefinition.json | Cross-version Profile for R4B.ActivityDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | ActivityDefinition | 5 |
| hl7.fhir.uv.order-catalog | StructureDefinition-LabProcedureDefinition.json | Laboratory Procedure Definition | trial-use | 2 | oo | 2026-06 | uv | ActivityDefinition | 1 |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-AdministrableProductDefinition-uv-epi.json | AdministrableProductDefinition (ePI) | trial-use | brr | 2026-07 | uv | AdministrableProductDefinition | 3 | |
| ch.fhir.ig.ch-idmp | StructureDefinition-ch-idmp-administrableproductdefinition.json | AdministrableProductDefinition | active | 2026-06 | ch | AdministrableProductDefinition | 2 | ||
| ch.fhir.ig.ch-epl | StructureDefinition-ch-idmp-administrableproductdefinition.json | AdministrableProductDefinition | active | 2026-04 | ch | AdministrableProductDefinition | 2 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-AdministrableProductDefinition.json | Cross-version Profile for R4B.AdministrableProductDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | AdministrableProductDefinition | 1 |
| hl7.fhir.uv.adverseeventclinicalcare | StructureDefinition-AdverseEvent-clinical-care.json | Adverse Event Clinical Care | informative | 1 | 2022-06 | uv | AdverseEvent | ||
| hl7.fhir.uv.ae-research-ig | StructureDefinition-AdverseEvent-clinical-research.json | Adverse Event Clinical Research | trial-use | 2 | brr | 2024-04 | uv | AdverseEvent | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-AdverseEvent.json | Cross-version Profile for R4B.AdverseEvent for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | AdverseEvent | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-AllergyIntolerance.json | Cross-version Profile for R4B.AllergyIntolerance for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | AllergyIntolerance | 1 |
| hl7.fhir.eu.base-r5 | StructureDefinition-allergyIntolerance-eu-core.json | AllergyIntolerance (EU core) | trial-use | 2 | 2026-08 | eu | AllergyIntolerance | ||
| hl7.at.fhir.tc.wg.scheduling.r5 | StructureDefinition-at-scheduling-appointment.json | HL7® AT Scheduling Appointment Profile | draft | 2026-09 | Appointment | 1 | |||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Appointment.json | Cross-version Profile for R4B.Appointment for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Appointment | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-AppointmentResponse.json | Cross-version Profile for R4B.AppointmentResponse for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | AppointmentResponse | |
| fhir.ig.trust.aitransparency | StructureDefinition-trust-ai-human-oversight.json | Trust AI Human Oversight Assessment | draft | 2026-10 | us | ArtifactAssessment | |||
| fhir.ig.trust.aitransparency | StructureDefinition-trust-ai-machine-execution-audit-event.json | Trust AI Execution Audit Event | draft | 2026-10 | us | AuditEvent | |||
| hl7.fhir.cr.meddyg.laboratory-results | StructureDefinition-cr-auditevent-laboratory-result.json | AuditEvent Resultado de Laboratorio | draft | 2026-09 | cr | AuditEvent | |||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-AuditEvent.json | Cross-version Profile for R4B.AuditEvent for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | AuditEvent | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Basic.json | Cross-version Profile for R4B.Basic for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Basic | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CatalogEntry.json | Cross-version Profile for R4B.CatalogEntry for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Basic | 1 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DocumentManifest.json | Cross-version Profile for R4B.DocumentManifest for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Basic | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ResearchDefinition.json | Cross-version Profile for R4B.ResearchDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Basic | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ResearchElementDefinition.json | Cross-version Profile for R4B.ResearchElementDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Basic | 4 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Binary.json | Cross-version Profile for R4B.Binary for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Binary | 4 |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-binary-epi.json | binary (ePI) | trial-use | brr | 2026-07 | uv | Binary | 1 | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-BiologicallyDerivedProduct.json | Cross-version Profile for R4B.BiologicallyDerivedProduct for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | BiologicallyDerivedProduct | 2 |
| hl7.fhir.uv.dicom-sr | StructureDefinition-dicom-sr-finding-site.json | Body Structure - DICOM SR Finding Site Mapping | trial-use | 2 | ii | 2026-09 | uv | BodyStructure | 2 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-BodyStructure.json | Cross-version Profile for R4B.BodyStructure for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | BodyStructure | |
| hl7.fhir.eu.base-r5 | StructureDefinition-bodyStructure-eu-core.json | BodyStructure (EU core) | trial-use | 2 | 2026-08 | eu | BodyStructure | 10 | |
| hl7.fhir.us.spl | StructureDefinition-OrganizationBundle.json | OrganizationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | 8 |
| hl7.fhir.us.spl | StructureDefinition-GDUFAFacilityIdentificationBundle.json | GDUFAFacilityIdentificationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-LabelerInactivationBundle.json | LabelerInactivationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-LabelerCodeRequestBundle.json | LabelerCodeRequestBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-NoChangeNotificationBundle.json | NoChangeNotificationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-EstablishmentRegistrationBundle.json | EstablishmentRegistrationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-EstablishmentInactivationBundle.json | EstablishmentInactivationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-GDUFAFacilityInactivationBundle.json | GDUFAFacilityInactivationBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-OutOfBusinessBundle.json | OutOfBusinessBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.spl | StructureDefinition-ProductSubmissionBundle.json | ProductSubmissionBundle | trial-use | 1 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-analytical-procedure-pq.json | Bundle – Analytical Procedure PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-batch-analysis-pq.json | Bundle – Batch Analysis PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-batch-formula-pq.json | Bundle – Batch Formula PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-product-batch-info-pq.json | Bundle – drug Product Batch Information PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-substance-batch-info-pq.json | Bundle – Drug Substance Batch Information PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-product-compatibility-pq.json | Bundle - Drug Product Compatibility PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-reference-standards-pq.json | Bundle – Drug Reference Standards PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-product-composition-pq.json | Bundle – Drug Product Composition PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-container-closure-system-pq.json | Bundle – Container Closure System PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-ectd-document-32p10.json | CMC eCTD 32P10 Document | trial-use | 2 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-ectd-document-32p32.json | CMC eCTD 32P32 Document | trial-use | 2 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-ectd-document-32p55.json | CMC eCTD 32P55 Document | trial-use | 2 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-ectd-document-32s10.json | CMC eCTD 32S10 Document | trial-use | 2 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-ectd-document-32s23.json | CMC eCTD 32S23 Document | trial-use | 2 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-ectd-document-32s3.json | CMC eCTD 32S3 Document | trial-use | 2 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-ectd-document-sp4151.json | CMC eCTD SP4151 Document | trial-use | 2 | brr | 2025-07 | us | Bundle | |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-bundle-document.json | Bundle: Dokument medyczny | active | 2026-01 | pl | Bundle | |||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-product-pq.json | Bundle - Drug Product PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-product-microbiological-attributes-pq.json | Bundle – Drug Product Microbiological Attributes PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-product-excipients-pq.json | Bundle – Drug Product Excipients PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-substance-general-properties-pq.json | Bundle – Drug Substance General Properties PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-substance-characterization-pq.json | Bundle – Drug Substance Characterization PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-product-impurities-pq.json | Bundle - Product Impurities PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-product-manufacturing-pq.json | Bundle - Product Manufacturing PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.cardx-cied | StructureDefinition-idco-bundle.json | Implantable Device Cardiac Observation (IDCO) Bundle | trial-use | 2 | cic | 2026-07 | uv | Bundle | |
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-organizations-pq.json | Bundle - Organizations PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.cr.meddyg.laboratory-results | StructureDefinition-cr-bundle-laboratory-result.json | Bundle Laboratorio | draft | 2026-09 | cr | Bundle | 1 | ||
| hl7.eu.fhir.gh | StructureDefinition-persona-collection.json | Persona Vector Collection | active | 2026-09 | eu | Bundle | |||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-product-process-validation-pq.json | Bundle - Product Process Validation PQ | active | brr | 2026-07 | uv | Bundle | ||
| ch.fhir.ig.ch-idmp | StructureDefinition-ch-idmp-bundle.json | Bundle | active | 2026-06 | ch | Bundle | |||
| ch.fhir.ig.ch-epl | StructureDefinition-ch-idmp-bundle.json | Bundle | active | 2026-04 | ch | Bundle | |||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-product-specification-pq.json | Bundle – Drug Product Specification PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-substance-specification-pq.json | Bundle – Drug Substance Specification PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-Bundle-drug-stability-pq.json | Bundle – Drug Stability PQ | active | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Bundle.json | Cross-version Profile for R4B.Bundle for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Bundle | |
| hl7.fhir.uv.order-catalog | StructureDefinition-ItemTransactionResponse.json | Catalog Item Transaction Request | trial-use | 2 | oo | 2026-06 | uv | Bundle | |
| hl7.fhir.uv.order-catalog | StructureDefinition-ItemTransactionRequest.json | Catalog Item Transaction Request | trial-use | 2 | oo | 2026-06 | uv | Bundle | |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-bundle-epi-type1.json | Bundle - ePI Type 1 | trial-use | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-bundle-epi-type2.json | Bundle - ePI Type 2 | trial-use | brr | 2026-07 | uv | Bundle | ||
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-bundle-epi-type3.json | Bundle - ePI Type 3 | trial-use | brr | 2026-07 | uv | Bundle | ||
| ru.core | StructureDefinition-core-bundle.json | Core Bundle (Пакет ресурсов) | active | 2026-09 | Bundle | ||||
| hl7.fhir.uv.application-feature | StructureDefinition-FeatureCapabilityStatement.json | Feature Capability Statement | trial-use | 2 | fhir | 2026-06 | uv | CapabilityStatement | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CapabilityStatement.json | Cross-version Profile for R4B.CapabilityStatement for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CapabilityStatement | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CarePlan.json | Cross-version Profile for R4B.CarePlan for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CarePlan | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CareTeam.json | Cross-version Profile for R4B.CareTeam for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CareTeam | 8 |
| ru.core | StructureDefinition-core-careteam.json | Core CareTeam (Бригада) | active | 2026-09 | CareTeam | 4 | |||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ChargeItem.json | Cross-version Profile for R4B.ChargeItem for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | ChargeItem | 1 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ChargeItemDefinition.json | Cross-version Profile for R4B.ChargeItemDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | ChargeItemDefinition | |
| hl7.fhir.uv.order-catalog | StructureDefinition-LabChargeItemDefinition.json | Laboratory Service Charge Item Definition | trial-use | 2 | oo | 2020-02 | uv | ChargeItemDefinition | 1 |
| de.netzwerk-universitaetsmedizin.ebm-cpg | StructureDefinition-study-citation.json | Study Citation | draft | 2022-03 | uv | Citation | 2 | ||
| hl7.fhir.pl.laboratory.r5 | StructureDefinition-pl-lab-citation-sourceInfo.json | Citation: Source information | draft | 2025-07 | pl | Citation | 1 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Citation.json | Cross-version Profile for R4B.Citation for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Citation | 3 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Claim.json | Cross-version Profile for R4B.Claim for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Claim | 1 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ClaimResponse.json | Cross-version Profile for R4B.ClaimResponse for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | ClaimResponse | 4 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ClinicalImpression.json | Cross-version Profile for R4B.ClinicalImpression for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | ClinicalImpression | |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-ClinicalUseDefinition-contraindication-uv-epi.json | ClinicalUseDefinition Contraindication (ePI) | trial-use | brr | 2026-07 | uv | ClinicalUseDefinition | 2 | |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-ClinicalUseDefinition-indication-uv-epi.json | ClinicalUseDefinition Indication (ePI) | trial-use | brr | 2026-07 | uv | ClinicalUseDefinition | 3 | |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-ClinicalUseDefinition-interaction-uv-epi.json | ClinicalUseDefinition Interaction (ePI) | trial-use | brr | 2026-07 | uv | ClinicalUseDefinition | 2 | |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-ClinicalUseDefinition-undesirable-effect-uv-epi.json | ClinicalUseDefinition Undesirable Effect (ePI) | trial-use | brr | 2026-07 | uv | ClinicalUseDefinition | 2 | |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-ClinicalUseDefinition-warning-uv-epi.json | ClinicalUseDefinition Warning (ePI) | trial-use | brr | 2026-07 | uv | ClinicalUseDefinition | 2 | |
| ch.fhir.ig.ch-idmp | StructureDefinition-ch-idmp-clinicalusedefinition-indication.json | ClinicalUseDefinition Indication | active | 2026-06 | ch | ClinicalUseDefinition | 1 | ||
| ch.fhir.ig.ch-epl | StructureDefinition-ch-idmp-clinicalusedefinition-indication.json | ClinicalUseDefinition Indication | active | 2026-04 | ch | ClinicalUseDefinition | 1 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ClinicalUseDefinition.json | Cross-version Profile for R4B.ClinicalUseDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | ClinicalUseDefinition | 3 |
| hl7.fhir.uv.order-catalog | StructureDefinition-ContraindicationDefinition.json | ClinicalUseDefinition as a contraindication | trial-use | 2 | oo | 2026-06 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.order-catalog | StructureDefinition-WarningDefinition.json | ClinicalUseDefinition as a warning | trial-use | 2 | oo | 2026-06 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.order-catalog | StructureDefinition-IndicationDefinition.json | ClinicalUseDefinition as a therapeutic indication | trial-use | 2 | oo | 2026-06 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.order-catalog | StructureDefinition-InteractionDefinition.json | ClinicalUseDefinition as an interaction | trial-use | 2 | oo | 2026-06 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.order-catalog | StructureDefinition-UndesirableEffectDefinition.json | ClinicalUseDefinition as an undesirable effect | trial-use | 2 | oo | 2026-06 | uv | ClinicalUseDefinition | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CodeSystem.json | Cross-version Profile for R4B.CodeSystem for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CodeSystem | 1 |
| fhir.ig.trust.aitransparency | StructureDefinition-trust-ai-patient-explanation.json | Trust AI Patient Explanation Communication | draft | 2026-10 | us | Communication | |||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Communication.json | Cross-version Profile for R4B.Communication for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Communication | 1 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CommunicationRequest.json | Cross-version Profile for R4B.CommunicationRequest for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CommunicationRequest | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CompartmentDefinition.json | Cross-version Profile for R4B.CompartmentDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CompartmentDefinition | |
| hl7.fhir.us.spl | StructureDefinition-ProductSubmissionDocument.json | ProductSubmissionDocument | trial-use | 1 | brr | 2025-07 | us | Composition | 2 |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-composition.json | Composition: Nagłówek dokumentu medycznego | active | 2026-01 | pl | Composition | 2 | ||
| hl7.eu.fhir.gh | StructureDefinition-focusedcomposition.json | Focused Composition Profile | active | 2026-09 | eu | Composition | |||
| hl7.fhir.pl.laboratory.r5 | StructureDefinition-pl-lab-composition.json | Composition: Laboratory Document Header | draft | 2025-07 | pl | Composition | |||
| hl7.fhir.cr.meddyg.laboratory-results | StructureDefinition-cr-composition-laboratory-result.json | Composition Laboratorio | draft | 2026-09 | cr | Composition | 1 | ||
| hl7.eu.fhir.gh | StructureDefinition-SummaryData.json | Summary Data Profile | active | 2026-09 | eu | Composition | |||
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-ectd-composition-sp4151.json | eCTD Specification | trial-use | 2 | brr | 2025-07 | us | Composition | 1 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-ectd-composition-32p32.json | eCTD Batch Formula | trial-use | 2 | brr | 2025-07 | us | Composition | 1 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-ectd-composition-32p55.json | eCTD Product Characterisation of Impurities | trial-use | 2 | brr | 2025-07 | us | Composition | 1 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-ectd-composition-32p10.json | eCTD Product Description and Composition | trial-use | 2 | brr | 2025-07 | us | Composition | 1 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-ectd-composition-32s23.json | eCTD Substance Control of Materials | trial-use | 2 | brr | 2025-07 | us | Composition | 1 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-ectd-composition-32s10.json | eCTD Substance General Information | trial-use | 2 | brr | 2025-07 | us | Composition | 1 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-ectd-composition-32s3.json | eCTD Substance Characterisation | trial-use | 2 | brr | 2025-07 | us | Composition | 1 |
| hl7.fhir.uv.pharm-quality | StructureDefinition-Composition-drug-pq.json | Composition - Drug PQ | active | brr | 2026-07 | uv | Composition | 1 | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Composition.json | Cross-version Profile for R4B.Composition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Composition | 2 |
| hl7.fhir.eu.base-r5 | StructureDefinition-composition-eu-core.json | Composition (EU core) | trial-use | 2 | 2026-08 | eu | Composition | ||
| hl7.fhir.uv.order-catalog | StructureDefinition-Catalog.json | Catalog | active | oo | 2026-06 | uv | Composition | ||
| hl7.fhir.uv.order-catalog | StructureDefinition-CatalogHeader.json | Catalog Header | active | oo | 2026-06 | uv | Composition | 1 | |
| hl7.fhir.uv.emedicinal-product-info | StructureDefinition-composition-epi-type1.json | Composition - ePI Type 1 to 4 | trial-use | brr | 2026-07 | uv | Composition | 3 | |
| ru.core | StructureDefinition-core-composition.json | Core Composition (Документ) | active | 2026-09 | Composition | ||||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-ConceptMap.json | Cross-version Profile for R4B.ConceptMap for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | ConceptMap | |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-condition-diagnosis.json | Condition: Rozpoznanie | active | 2026-01 | pl | Condition | 1 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Condition.json | Cross-version Profile for R4B.Condition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Condition | 11 |
| hl7.fhir.eu.base-r5 | StructureDefinition-condition-eu-core.json | Condition (EU core) | trial-use | 2 | 2026-08 | eu | Condition | 1 | |
| hl7.fhir.pl.laboratory.r5 | StructureDefinition-pl-lab-conditionDefinition-reasonForTest.json | SubstanceDefinition: Reason for test (PL) | draft | 2025-07 | pl | ConditionDefinition | 1 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Consent.json | Cross-version Profile for R4B.Consent for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Consent | 1 |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-contract.json | Contract: Umowa | active | 2026-01 | pl | Contract | 1 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Contract.json | Cross-version Profile for R4B.Contract for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Contract | 3 |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-coverage.json | Coverage: Produkt medyczny | active | 2026-01 | pl | Coverage | 2 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Coverage.json | Cross-version Profile for R4B.Coverage for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Coverage | 4 |
| ru.core | StructureDefinition-core-coverage.json | Core Coverage (Страховое покрытие) | active | 2026-09 | Coverage | 1 | |||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CoverageEligibilityRequest.json | Cross-version Profile for R4B.CoverageEligibilityRequest for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CoverageEligibilityRequest | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-CoverageEligibilityResponse.json | Cross-version Profile for R4B.CoverageEligibilityResponse for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | CoverageEligibilityResponse | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DetectedIssue.json | Cross-version Profile for R4B.DetectedIssue for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DetectedIssue | 4 |
| hl7.fhir.uv.cardx-cied | StructureDefinition-cied-device-lead.json | Device - Cardiovascular Implantable Electronic Device (CIED) Lead | trial-use | 2 | cic | 2026-07 | uv | Device | 1 |
| hl7.fhir.uv.cardx-cied | StructureDefinition-cied-device.json | Device - Cardiovascular Implantable Electronic Device (CIED) | trial-use | 2 | cic | 2026-07 | uv | Device | 5 |
| hl7.fhir.uv.cardx-cied | StructureDefinition-cied-monitor.json | Device - CIED Monitor Profile | trial-use | 2 | cic | 2026-07 | uv | Device | 2 |
| fhir.ig.trust.aitransparency | StructureDefinition-trust-ai-device.json | Trust AI System Device | draft | 2026-10 | us | Device | 3 | ||
| hl7.fhir.uv.dicom-sr | StructureDefinition-dicom-general-equipment.json | Device - DICOM General Equipment Mapping | trial-use | 2 | ii | 2026-09 | uv | Device | 3 |
| hl7.fhir.uv.dicom-sr | StructureDefinition-dicom-participant-device.json | Device - DICOM Participant Device Mapping | trial-use | 2 | ii | 2026-09 | uv | Device | 1 |
| hl7.fhir.uv.dicom-sr | StructureDefinition-algorithm-identification.json | Device - DICOM SR Algorithm Identification Mapping | trial-use | 2 | ii | 2026-09 | uv | Device | 2 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Device.json | Cross-version Profile for R4B.Device for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Device | 16 |
| hl7.fhir.uv.cardx-cied | StructureDefinition-cied-device-association.json | Device Association - Cardiovascular Implantable Electronic Device (CIED) | trial-use | 2 | cic | 2026-07 | uv | DeviceAssociation | 1 |
| hl7.fhir.uv.xver-r2.r5 | StructureDefinition-profile-Device-for-DeviceAssociation.json | Cross-version Profile for DSTU2.Device for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceAssociation | 5 |
| hl7.fhir.uv.xver-r4.r5 | StructureDefinition-profile-Device-for-DeviceAssociation.json | Cross-version Profile for R4.Device for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceAssociation | 8 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Device-for-DeviceAssociation.json | Cross-version Profile for R4B.Device for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceAssociation | 8 |
| hl7.fhir.uv.xver-r3.r5 | StructureDefinition-profile-Device-for-DeviceAssociation.json | Cross-version Profile for STU3.Device for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceAssociation | 9 |
| hl7.fhir.uv.pharm-quality | StructureDefinition-DeviceDefinition-drug-pq.json | DeviceDefinition - Drug PQ | active | brr | 2026-07 | uv | DeviceDefinition | 3 | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DeviceDefinition.json | Cross-version Profile for R4B.DeviceDefinition for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceDefinition | 4 |
| hl7.fhir.uv.order-catalog | StructureDefinition-DeviceModel.json | Device Model | trial-use | 2 | oo | 2022-02 | uv | DeviceDefinition | 1 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DeviceMetric.json | Cross-version Profile for R4B.DeviceMetric for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceMetric | 2 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DeviceRequest.json | Cross-version Profile for R4B.DeviceRequest for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceRequest | |
| hl7.fhir.uv.xver-r2.r5 | StructureDefinition-profile-DeviceUseStatement-for-DeviceUsage.json | Cross-version Profile for DSTU2.DeviceUseStatement for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceUsage | |
| hl7.fhir.uv.xver-r4.r5 | StructureDefinition-profile-DeviceUseStatement-for-DeviceUsage.json | Cross-version Profile for R4.DeviceUseStatement for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceUsage | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DeviceUseStatement-for-DeviceUsage.json | Cross-version Profile for R4B.DeviceUseStatement for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceUsage | |
| hl7.fhir.uv.xver-r3.r5 | StructureDefinition-profile-DeviceUseStatement-for-DeviceUsage.json | Cross-version Profile for STU3.DeviceUseStatement for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DeviceUsage | |
| hl7.fhir.uv.cardx-cied | StructureDefinition-cied-diagnostic-report.json | CIED Diagnostic Report Profile | trial-use | 2 | cic | 2026-07 | uv | DiagnosticReport | 2 |
| hl7.fhir.cr.meddyg.laboratory-results | StructureDefinition-cr-diagnostic-report-laboratory-result.json | DiagnosticReport Laboratorio | draft | 2026-09 | cr | DiagnosticReport | 3 | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-DiagnosticReport-analysis-drug-pq.json | DiagnosticReport - Analysis Drug PQ | active | brr | 2026-07 | uv | DiagnosticReport | 8 | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DiagnosticReport.json | Cross-version Profile for R4B.DiagnosticReport for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DiagnosticReport | 17 |
| hl7.fhir.eu.base-r5 | StructureDefinition-diagnosticReport-eu-core.json | DiagnosticReport (EU core) | trial-use | 2 | 2026-08 | eu | DiagnosticReport | ||
| hl7.fhir.pl.laboratory.r5 | StructureDefinition-pl-lab-diagnosticReport.json | DiagnosticReport: Labortory Report (PL) | draft | 2025-07 | pl | DiagnosticReport | |||
| ru.core | StructureDefinition-core-diagnosticreport.json | Core DiagnosticReport (Протокол исследования) | active | 2026-09 | DiagnosticReport | ||||
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-pqcmc-graphic-reference.json | Graphic Reference | trial-use | 2 | brr | 2025-07 | us | DocumentReference | 9 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-pqcmc-structure-reference.json | Structure Data Reference | trial-use | 2 | brr | 2025-07 | us | DocumentReference | 8 |
| fhir.ig.trust.aitransparency | StructureDefinition-trust-ai-model-card.json | Trust AI Model Card | draft | 2026-10 | us | DocumentReference | 1 | ||
| hl7.fhir.uv.rtq-ig | StructureDefinition-rtq-documentreference.json | RTQ Document Reference | draft | 2025-11 | uv | DocumentReference | 2 | ||
| hl7.fhir.us.spl | StructureDefinition-SPLDocumentReference.json | SPLDocumentReference | trial-use | 1 | brr | 2025-07 | us | DocumentReference | 1 |
| hl7.fhir.us.pq-cmc-fda | StructureDefinition-cmc-document-reference.json | Document Reference Attachment | trial-use | 2 | brr | 2025-07 | us | DocumentReference | 2 |
| hl7.eu.fhir.gh | StructureDefinition-AdditionalSupportMaterial.json | Additional Support Material Profile | active | 2026-09 | eu | DocumentReference | |||
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-documentIdentity.json | DocumentReference: Identyfikator i wersja dokumentu medycznego | active | 2026-01 | pl | DocumentReference | |||
| hl7.fhir.uv.apix | StructureDefinition-apix-documentreference.json | APIX Regulatory DocumentReference | trial-use | 1 | brr | 2025-12 | uv | DocumentReference | |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-cdaDocumentMetadata.json | DocumentReference: Metadane dokumentu medycznego HL7 CDA | active | 2026-01 | pl | DocumentReference | |||
| ch.fhir.ig.ch-idmp | StructureDefinition-ch-idmp-documentreference.json | DocumentReference | active | 2026-06 | ch | DocumentReference | 2 | ||
| ch.fhir.ig.ch-epl | StructureDefinition-ch-idmp-documentreference.json | DocumentReference | active | 2026-04 | ch | DocumentReference | 2 | ||
| hl7.fhir.uv.pharm-quality | StructureDefinition-DocumentReference-drug-pq.json | DocumentReference - Drug PQ | active | brr | 2026-07 | uv | DocumentReference | 3 | |
| hl7.fhir.uv.xver-r2.r5 | StructureDefinition-profile-Media-for-DocumentReference.json | Cross-version Profile for DSTU2.Media for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DocumentReference | |
| hl7.fhir.uv.xver-r4.r5 | StructureDefinition-profile-Media-for-DocumentReference.json | Cross-version Profile for R4.Media for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DocumentReference | 4 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DocumentReference.json | Cross-version Profile for R4B.DocumentReference for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DocumentReference | 25 |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Media-for-DocumentReference.json | Cross-version Profile for R4B.Media for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DocumentReference | 4 |
| hl7.fhir.uv.xver-r3.r5 | StructureDefinition-profile-Media-for-DocumentReference.json | Cross-version Profile for STU3.Media for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DocumentReference | |
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-DomainResource.json | Cross-version Profile for R4B.DomainResource for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | DomainResource | |
| hl7.fhir.pl.base.r5 | StructureDefinition-pl-base-Encounter.json | Encounter: Wizyta/pobyt | active | 2026-01 | pl | Encounter | 3 | ||
| ee.fhir.base | StructureDefinition-ee-encounter.json | EEBase Encounter | draft | 2025-11 | ee | Encounter | 2 | ||
| hl7.fhir.uv.xver-r4b.r5 | StructureDefinition-profile-Encounter.json | Cross-version Profile for R4B.Encounter for use in FHIR R5 | trial-use | 0 | fhir | 2026-03 | uv | Encounter | 6 |
FHIR
FHIRsmith